Rights and permissions
About this article
Cite this article
Imatinib cost effective vs bone marrow transplantation in CML. Pharmacoecon. Outcomes News 475, 9 (2005). https://doi.org/10.2165/00151234-200504750-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504750-00020